Status:
ACTIVE_NOT_RECRUITING
Efficacy of Magnesium Sulfate Bolus in Pediatric Patients With Bronchiolitis
Lead Sponsor:
University of Louisville
Conditions:
Bronchiolitis, Viral
Eligibility:
All Genders
1-12 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to more rigorously evaluate the response to a single bolus of magnesium sulfate in a population of patients with moderate to severe bronchiolitis. The primary outcome will...
Detailed Description
This randomized placebo-controlled pilot study is designed to evaluate the above referenced outcomes. Study drug initiation will occur in the local pediatric intensive care unit in patients with a cli...
Eligibility Criteria
Inclusion
- Infants under 12 months of age
- Admitted to the pediatric intensive care unit
- Moderate/severe bronchiolitis using MPIS
- Less than 24 hours of admission to the PICU
- Parent/LAR consents for infant to participate
Exclusion
- Patients with the following conditions are ineligible: chronic lung disease, unrepaired congenital heart disease, and cyanotic heart disease.
Key Trial Info
Start Date :
July 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04740294
Start Date
July 21 2021
End Date
July 1 2025
Last Update
October 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Norton Children's Hospital
Louisville, Kentucky, United States, 40202